Electrochemical quantification of the Alzheimer’s disease amyloid-β (1–40) using amyloid-β fibrillization promoting peptide

Amyloid-β peptide (Aβ) is believed to be an important biomarker for the early diagnosis of Alzheimer’s disease. Therefore, practical and reliable methods to assay Aβ levels have been coveted. In this study, a rapid, sensitive, and selective electrochemical method for Aβ(1–40) detection using Cu2+ re...

Full description

Bibliographic Details
Main Authors: Satoshi Fujii, Daiki Sono, Kaoru Matsubara, Hitoshi Abe
Format: Article
Language:English
Published: Elsevier 2015-12-01
Series:Sensing and Bio-Sensing Research
Online Access:http://www.sciencedirect.com/science/article/pii/S2214180415300167
_version_ 1819267124660535296
author Satoshi Fujii
Daiki Sono
Kaoru Matsubara
Hitoshi Abe
author_facet Satoshi Fujii
Daiki Sono
Kaoru Matsubara
Hitoshi Abe
author_sort Satoshi Fujii
collection DOAJ
description Amyloid-β peptide (Aβ) is believed to be an important biomarker for the early diagnosis of Alzheimer’s disease. Therefore, practical and reliable methods to assay Aβ levels have been coveted. In this study, a rapid, sensitive, and selective electrochemical method for Aβ(1–40) detection using Cu2+ redox cycling on peptide-modified gold electrodes was developed. A 19-residue peptide that can promote Aβ fibrillization (AFPP) was immobilized onto a gold electrode. After incubating an Aβ solution with the modified electrode for 1 h, a Cu2+ solution was added and cyclic voltammetry measurements were conducted. The voltammetric response was found to be proportional to the Aβ(1–40) concentration in the 0.1–5 μM range, and a detection limit of 18 nM was achieved. Washing with sodium hydroxide and ethylenediaminetetraacetate solutions easily reinitialized the modified electrode. Results obtained using the reinitialized electrode showed good reproducibility. Furthermore, when another amyloidogenic and Cu2+-binding protein amylin was used as the target, no voltammetric response was observed. These results indicate that the AFPP-modified electrode provides a promising, label-free, sensitive, selective, cost-effective, and easy method for the quantification of Aβ. Keywords: Amyloid-β, Alzheimer’s disease (AD), Fibrillization, Electrochemical detection, Nanobiochip, Cu redox
first_indexed 2024-12-23T21:12:11Z
format Article
id doaj.art-c5cef34a3ef14df795b23d12c1286f5a
institution Directory Open Access Journal
issn 2214-1804
language English
last_indexed 2024-12-23T21:12:11Z
publishDate 2015-12-01
publisher Elsevier
record_format Article
series Sensing and Bio-Sensing Research
spelling doaj.art-c5cef34a3ef14df795b23d12c1286f5a2022-12-21T17:31:01ZengElsevierSensing and Bio-Sensing Research2214-18042015-12-016712Electrochemical quantification of the Alzheimer’s disease amyloid-β (1–40) using amyloid-β fibrillization promoting peptideSatoshi Fujii0Daiki Sono1Kaoru Matsubara2Hitoshi Abe3Department of Nanobiochemistry, FIRST (Frontiers of Innovative Research in Science and Technology), Konan University, 7-1-20 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan; Corresponding author.Department of Nanobiochemistry, FIRST (Frontiers of Innovative Research in Science and Technology), Konan University, 7-1-20 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, JapanDepartment of Nanobiochemistry, FIRST (Frontiers of Innovative Research in Science and Technology), Konan University, 7-1-20 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, JapanDepartment of Chemistry, Faculty of Science and Technology, Konan University, 8-9-1 Okamoto, Higashinada-ku, Kobe, Hyogo 658-8501, JapanAmyloid-β peptide (Aβ) is believed to be an important biomarker for the early diagnosis of Alzheimer’s disease. Therefore, practical and reliable methods to assay Aβ levels have been coveted. In this study, a rapid, sensitive, and selective electrochemical method for Aβ(1–40) detection using Cu2+ redox cycling on peptide-modified gold electrodes was developed. A 19-residue peptide that can promote Aβ fibrillization (AFPP) was immobilized onto a gold electrode. After incubating an Aβ solution with the modified electrode for 1 h, a Cu2+ solution was added and cyclic voltammetry measurements were conducted. The voltammetric response was found to be proportional to the Aβ(1–40) concentration in the 0.1–5 μM range, and a detection limit of 18 nM was achieved. Washing with sodium hydroxide and ethylenediaminetetraacetate solutions easily reinitialized the modified electrode. Results obtained using the reinitialized electrode showed good reproducibility. Furthermore, when another amyloidogenic and Cu2+-binding protein amylin was used as the target, no voltammetric response was observed. These results indicate that the AFPP-modified electrode provides a promising, label-free, sensitive, selective, cost-effective, and easy method for the quantification of Aβ. Keywords: Amyloid-β, Alzheimer’s disease (AD), Fibrillization, Electrochemical detection, Nanobiochip, Cu redoxhttp://www.sciencedirect.com/science/article/pii/S2214180415300167
spellingShingle Satoshi Fujii
Daiki Sono
Kaoru Matsubara
Hitoshi Abe
Electrochemical quantification of the Alzheimer’s disease amyloid-β (1–40) using amyloid-β fibrillization promoting peptide
Sensing and Bio-Sensing Research
title Electrochemical quantification of the Alzheimer’s disease amyloid-β (1–40) using amyloid-β fibrillization promoting peptide
title_full Electrochemical quantification of the Alzheimer’s disease amyloid-β (1–40) using amyloid-β fibrillization promoting peptide
title_fullStr Electrochemical quantification of the Alzheimer’s disease amyloid-β (1–40) using amyloid-β fibrillization promoting peptide
title_full_unstemmed Electrochemical quantification of the Alzheimer’s disease amyloid-β (1–40) using amyloid-β fibrillization promoting peptide
title_short Electrochemical quantification of the Alzheimer’s disease amyloid-β (1–40) using amyloid-β fibrillization promoting peptide
title_sort electrochemical quantification of the alzheimer s disease amyloid β 1 40 using amyloid β fibrillization promoting peptide
url http://www.sciencedirect.com/science/article/pii/S2214180415300167
work_keys_str_mv AT satoshifujii electrochemicalquantificationofthealzheimersdiseaseamyloidb140usingamyloidbfibrillizationpromotingpeptide
AT daikisono electrochemicalquantificationofthealzheimersdiseaseamyloidb140usingamyloidbfibrillizationpromotingpeptide
AT kaorumatsubara electrochemicalquantificationofthealzheimersdiseaseamyloidb140usingamyloidbfibrillizationpromotingpeptide
AT hitoshiabe electrochemicalquantificationofthealzheimersdiseaseamyloidb140usingamyloidbfibrillizationpromotingpeptide